Integrated Filing — IndAS



General information about company

Scrip Code 542650
NSE Symbol METROPOLIS
MSEI Symbol NOTLISTED
ISIN INE112L01020
Name of company Metropolis Healthcare Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 04-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 28-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pathology Services
Start date and time of board meeting 04-11-2025   14:15:00
End date and time of board meeting 04-11-2025   17:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 42,919.14 81,525.46
Other income 89.10 840.74
Total income 43,008.24 82,366.20
2 Expenses
(a) Cost of materials consumed 8,774.85 16,679.78
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 9,539.33 18,767.25
(e) Finance costs 568.20 1,088.04
(f) Depreciation, depletion and amortisation expense 3,240.76 6,325.28
(f) Other Expenses
1 Laboratory testing charges 496.74 1,064.10
2 Other expenses 13,285.79 25,216.14
Total other expenses 13,782.53 26,280.24
Total expenses 35,905.67 69,140.59
3 Total profit before exceptional items and tax 7,102.57 13,225.61
4 Exceptional items 0.00 0.00
5 Total profit before tax 7,102.57 13,225.61
6 Tax expense
7 Current tax 2,024.45 3,787.58
8 Deferred tax (210.89) (375.51)
9 Total tax expenses 1,813.56 3,412.07
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,289.01 9,813.54
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,289.01 9,813.54
17 Other comprehensive income net of taxes 199.58 (18.30)
18 Total Comprehensive Income for the period 5,488.59 9,795.24
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 5,266.812 9,772.886
Total profit or loss, attributable to non-controlling interests 22.203 40.645
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 5,467.169 9,755.306
Total comprehensive income for the period attributable to owners of parent non-controlling interests 21.416 39.925
21 Details of equity share capital
Paid-up equity share capital 1,036.16 1,036.16
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 10.17 18.87
Diluted earnings (loss) per share from continuing operations 10.13 18.79
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 10.17 18.87
Diluted earnings (loss) per share from continuing and discontinued operations 10.13 18.79
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Refer the financial results pdf uploaded on stock exchange for the full notes



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 20,277.35
Capital work-in-progress
Investment property
Goodwill 66,441.46
Other intangible assets 54,472.20
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 175.28
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets 2,292.16
Total non-current financial assets 2,467.44
Deferred tax assets (net) 3,827.45
Other non-current assets 16,705.54
Total non-current assets 1,64,191.44
2 Current assets
Inventories 4,281.40
Current financial asset
Current investments 1,949.12
Trade receivables, current 17,608.25
Cash and cash equivalents 5,016.48
Bank balance other than cash and cash equivalents 992.15
Loans, current 0.00
Other current financial assets 1,029.50
Total current financial assets 26,595.50
Current tax assets (net)
Other current assets 4,188.07
Total current assets 35,064.97
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,99,256.41
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,036.16
Other equity 1,42,212.79
Total equity attributable to owners of parent 1,43,248.95
Non controlling interest 1,063.29
Total equity 1,44,312.24
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 11,122.22
Total non-current financial liabilities 11,122.22
Provisions, non-current 3,025.10
Deferred tax liabilities (net) 10,592.49
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 24,739.81
Current liabilities
Current financial liabilities
Borrowings, current 2,071.32
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 982.29
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 11,507.31
Total Trade payable 12,489.60
Other current financial liabilities 2,787.71
Total current financial liabilities 17,348.63
Other current liabilities 9,004.35
Provisions, current 1,074.23
Current tax liabilities (Net) 2,777.15
Deferred government grants, Current
Total current liabilities 30,204.36
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 54,944.17
Total equity and liabilites 1,99,256.41
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) Refer the financial results pdf uploaded on stock exchange for the full notes



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss 180.59 224.75
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss (380.17) (206.45)
5 Total Other comprehensive income 199.58 (18.30)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 13,225.61
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,088.04
Adjustments for decrease (increase) in inventories 590.09
Adjustments for decrease (increase) in trade receivables, current (3,828.44)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,687.81)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current (187.09)
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (635.56)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (486.89)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 6,325.28
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 230.13
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (193.73)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (135.13)
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 397.01
Adjustments for fair value losses (gains) 238.76
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 820.41
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 2,535.07
Net cash flows from (used in) operations 15,760.68
Dividends received 0.00
Interest paid 0.00
Interest received (101.90)
Income taxes paid (refund) 2,745.80
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 12,912.98
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 9,920.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 2,495.28
Proceeds from sales of investment property 5,116.71
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 1,738.56
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 39.19
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 629.16
Net cash flows from (used in) investing activities (8,368.78)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares (655.90)
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.15
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 651.92
Repayments of borrowings 0.00
Payments of lease liabilities 3,959.81
Dividends paid 0.00
Interest paid 133.71
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (948.00)
Net cash flows from (used in) financing activities (3,733.55)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 810.65
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 206.45
Net increase (decrease) in cash and cash equivalents 1,017.10
Cash and cash equivalents cash flow statement at beginning of period 3,999.39
Cash and cash equivalents cash flow statement at end of period 5,016.49